Back to Research Hub
Lantheus Holdings, Inc.
LNTH
$99.98-0.03 (-0.03%)
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
StreetsValue research for Lantheus Holdings, Inc. (LNTH)
Members get the full report for Lantheus Holdings, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.